Cargando…

Peptide Based Imaging Agents for HER2 Imaging in Oncology

Breast cancer continues to be the most lethal cancer type in women and one of the most diagnosed. Understanding Breast cancer receptor status is one of the most vital processes for determining treatment options. One type of breast cancer, human epidermal growth factor receptor 2 (HER2) positive, has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ducharme, Maxwell, Lapi, Suzanne E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513396/ https://www.ncbi.nlm.nih.gov/pubmed/32957830 http://dx.doi.org/10.1177/1536012120960258

Ejemplares similares

Evaluation of (68)Ga-Radiolabeled Peptides for HER2 PET Imaging
por: Ducharme, Maxwell, et al.
Publicado: (2022)

Targeting HER2 in Nuclear Medicine for Imaging and Therapy
por: Massicano, Adriana V. F., et al.
Publicado: (2018)

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
por: Tornesello, Anna Lucia, et al.
Publicado: (2017)

Anti-HER2 imaging agents for breast cancer imaging
por: Tolner, B, et al.
Publicado: (2010)

Use of contrast agents in oncological imaging: magnetic resonance imaging
por: Morana, Giovanni, et al.
Publicado: (2013)

Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology
por: Kasten, Benjamin B., et al.
Publicado: (2019)

Positron Emission Tomography Imaging of Macrophages in Cancer
por: Parker, Candace C., et al.
Publicado: (2021)

Radiolabeled Cationic Peptides for Targeted Imaging of Infection
por: Aweda, Tolulope A., et al.
Publicado: (2019)

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
por: Thian, Yee Liang, et al.
Publicado: (2013)

Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics
por: Cavallaro, Palmira Alessia, et al.
Publicado: (2023)

Imaging in Oncology
por: Hague, J, et al.
Publicado: (2005)

HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery
por: Geng, Lingling, et al.
Publicado: (2016)

Imaging in neuro-oncology
por: Nandu, Hari, et al.
Publicado: (2018)

[(89)Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models
por: Lu, Yun, et al.
Publicado: (2021)

A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer
por: Lv, Wei, et al.
Publicado: (2018)

Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe
por: Honarvar, Hadis, et al.
Publicado: (2018)

New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging
por: Radford, Lauren L., et al.
Publicado: (2019)

Vaccination against Her-2/neu, with focus on peptide-based vaccines
por: Tobias, J., et al.
Publicado: (2022)

PET Imaging of the Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68
por: Houson, Hailey A., et al.
Publicado: (2022)

Molecular imaging of HER2 receptor: Targeting HER2 for imaging and therapy in nuclear medicine
por: Miladinova, Daniela
Publicado: (2023)

CT-based ventilation imaging in radiation oncology
por: Vinogradskiy, Yevgeniy
Publicado: (2019)

Peptide-based PET imaging agent of tumor TIGIT expression
por: Weng, Dinghu, et al.
Publicado: (2023)

Antimicrobial Peptides as Infection Imaging Agents: Better Than Radiolabeled Antibiotics
por: Akhtar, Muammad Saeed, et al.
Publicado: (2012)

Pitfalls in paediatric oncology imaging
por: Wessely, K., et al.
Publicado: (2011)

Optical imaging probes in oncology
por: Martelli, Cristina, et al.
Publicado: (2016)

Trends in oncologic hybrid imaging
por: Wibmer, Andreas G., et al.
Publicado: (2018)

Updates in imaging in ocular oncology
por: Davila, Jose R., et al.
Publicado: (2019)

Multiplex imaging in immuno-oncology
por: Zhao, Chen, et al.
Publicado: (2023)

The skull base in oncologic imaging
por: Chong, V
Publicado: (2003)

Cyclodextrin-Based Contrast Agents for Medical Imaging
por: Shepelytskyi, Yurii, et al.
Publicado: (2020)

Review: Radionuclide Molecular Imaging Targeting HER2 in Breast Cancer with a Focus on Molecular Probes into Clinical Trials and Small Peptides
por: Ge, Shushan, et al.
Publicado: (2021)

Targeted Molecular Imaging in Oncology
por: Brock, C
Publicado: (2002)

Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo
por: Guan, Siao-Syun, et al.
Publicado: (2018)

Diffusion-Weighted Imaging in Oncology: An Update
por: Messina, Carmelo, et al.
Publicado: (2020)

New frontiers in pediatric oncologic imaging
por: McCarville, M. Beth
Publicado: (2008)

PET-CT imaging in pediatric oncology
por: McCarville, M. Beth
Publicado: (2009)

HER2 Targeted Molecular MR Imaging Using a De Novo Designed Protein Contrast Agent
por: Qiao, Jingjuan, et al.
Publicado: (2011)

Peptide probes derived from pertuzumab by molecular dynamics modeling for HER2 positive tumor imaging
por: Yang, Xiaoliang, et al.
Publicado: (2017)

Dendrimer-based contrast agents for PET imaging
por: Zhao, Lingzhou, et al.
Publicado: (2017)

The HER2-low revolution in breast oncology: steps forward and emerging challenges
por: Nicolò, Eleonora, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k8bao7a1vjtnj67h5jhth69inh